Concepedia
Statistics
Publications
12
Citations
1.1K
H-Index
11
Active since
2003
Affiliations
National Cancer Institute(Current)
Molecular Oncology (United States)
Merck & Co., Inc., Rahway, NJ, USA (United States)
Science Applications International Corporation (United States)
Bristol-Myers Squibb (United States)
Michael Cerra is an author at National Cancer Institute specializing in oncology, tumor biology, and cancer research.
Top concepts
MedicineOncologyCell BiologyRadiotherapyTumor BiologyCancer ResearchRadiation OncologyCancer Cell BiologyPharmacologyCancer Biology
Publications per year
2003–2021
Enhanced Radiation-Induced Cell Killing and Prolongation of γH2AX Foci Expression by the Histone Deacetylase Inhibitor MS-275
Kevin Camphausen, William Burgan, Michael Cerra et al. · Cancer Research · 2004 · 211 citations
Enhancement of <i>in vitro</i> and <i>in vivo</i> tumor cell radiosensitivity by valproic acid
Kevin Camphausen, David Cerna, Tamalee Scott et al. · International Journal of Cancer · 2004 · 191 citations · Full text
Engineering, Radiation Effect, Radiation Biology +18
Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity.
Jeffery S. Russell, Kristin J. Brady, William Burgan et al. · PubMed · 2003 · 161 citations
Tyrosine Kinase, Radiation Effect, Pathology +17
Enhancement of <i>In vitro</i> and <i>In vivo</i> Tumor Cell Radiosensitivity by the DNA Methylation Inhibitor Zebularine
Hideaki Dote, David Cerna, William Burgan et al. · Clinical Cancer Research · 2005 · 108 citations · Full text
Engineering, Radiation Effect, Dna Methylation +19
PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation
Simon Wilson, Fraz A. Ismat, Zhaoqing Wang et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2017 · 104 citations · Full text
1–5 of 12